Clinical Memory Research
Organisational unit: Division
We embrace the big picture of dementia and memory diseases. This includes the course from origin and early detection to treatment. The scope includes a wide range of diagnoses, among these Alzheimers Disease, Lewy Body Dementia and Parkinsons Disease. Early detection of Alzheimers Disease, by using new markers, is one of our most promising fields. Spinal fluid test concepts, developed by us, are now in daily clinical use. In clinical studies we promote innovative use of modern medical imaging concepts, making it possible to visualize the neurological processes in the human brain. The research group is a driving force in The Swedish BIOFINDER Study. The study has been initiated to discover key mechanisms in Alzheimers disease, Parkinsons disease and other neurodegenerative disorders. Health care development in the field of memory diseases can support the patients daily life. We are developing new health care methodology in collaboration with Swedish health care providers.
Recent research outputs
Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: A 22-year follow-up studyThordardottir, S., Rodriguez-Vieitez, E., Almkvist, O., Ferreira, D., Saint-Aubert, L., Kinhult-Ståhlbom, A., Thonberg, H., Michael Schöll, Westman, E., Wall, A., Eriksdotter, M., Zetterberg, H., Blennow, K., Nordberg, A. & Graff, C. 2018 May 10 In : Alzheimer's Research and Therapy. 10, 1, 45
Research output: Contribution to journal › Article
View All (525)